Advertisement

O.C. BUSINESS PLUS | ORANGE COUNTY BRIEFLY

Cortex in the Black for Last Fiscal Quarter

August 30, 2000

Cortex Pharmaceuticals Inc., Irvine developer of drug therapies for neurological and psychiatric disorders reported that it earned nearly $1.2 million, or 7 cents a share, in the fiscal fourth quarter, compared with a loss of $469,000, or 3 cents a share, a year earlier. Revenue for the three months ended June 30 more than quadrupled to $2.8 million from $690,000.

For the year, the company posted a loss of $197,000, or 1 cent a share, compared with a loss of $1.6 million, or 12 cents a share, the previous year. Revenue rose 72% to $5.5 million.

Advertisement
Los Angeles Times Articles
|
|
|